WO2021098693A1 - 一种纳米抗菌葡糖基复合粒子及其加工方法与应用 - Google Patents

一种纳米抗菌葡糖基复合粒子及其加工方法与应用 Download PDF

Info

Publication number
WO2021098693A1
WO2021098693A1 PCT/CN2020/129605 CN2020129605W WO2021098693A1 WO 2021098693 A1 WO2021098693 A1 WO 2021098693A1 CN 2020129605 W CN2020129605 W CN 2020129605W WO 2021098693 A1 WO2021098693 A1 WO 2021098693A1
Authority
WO
WIPO (PCT)
Prior art keywords
glucosyl
nanoparticles
reaction
natural
composite particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2020/129605
Other languages
English (en)
French (fr)
Inventor
缪铭
刘瑶
支朝晖
张涛
金征宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Publication of WO2021098693A1 publication Critical patent/WO2021098693A1/zh
Priority to US17/744,811 priority Critical patent/US12336546B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/7295—Antibiotics
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
    • A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/779—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/783—Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/524—Preservatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Definitions

  • the invention relates to a nano antibacterial glucose-based composite particle and a processing method and application thereof, and belongs to the technical field of modern food processing.
  • Nanotechnology is a new frontier high technology that emerged in the late 1980s and is developing rapidly. It involves modern physics, chemistry, biology, medicine, materials science, information science, energy science and advanced manufacturing science. It is a highly interdisciplinary subject. . Nanotechnology is the study of the properties and applications of materials at the nanometer scale (usually 1-100nm). The use of nanotechnology can extend the means and capabilities of civilization to understand and transform the material world to atoms and molecules. At the nanometer scale, matter has the characteristics of quantum size effect, surface effect, and macroscopic quantum tunneling effect, and exhibits characteristics that are different from the physical, chemistry, optics, mechanics, and biology of matter at the macroscopic scale or not available at the macroscopic scale.
  • nanotechnology has had a profound impact on the world, and its application fields have slowly penetrated into traditional industries such as food, agriculture, and medicine.
  • the developed countries in Europe and the United States have invested a lot of manpower and material resources in the research and development of nanoscale products, such as Active factor nano-carriers, food antibacterial packaging, nano-encapsulated chemical inputs, nano-emulsions, nano-sensors, etc.
  • nano-Ag and nano-TiO 2 are both toxic to a certain degree, which may have a negative impact on human health and the environment, and they are naturally degradable.
  • the present invention provides a nano antibacterial glucosyl composite particle.
  • the nano antibacterial glucosyl composite particle of the present invention has excellent antibacterial properties and can be used as a matrix material in the fields of food, textiles, daily chemicals, medicine, etc. .
  • the method has the characteristics of simple process, controllable process, environmental protection and the like.
  • the first object of the present invention is to provide a processing method of nano antibacterial glucosyl composite particles, the method includes the following steps:
  • the natural glucosyl nanoparticles are derived from plants, animals or microorganisms, wherein the plant and animal sources are obtained by extracting from growing grain grains, algae and certain animal tissues, and the microbial sources are cultured and fermented. Obtained by extracting the bacteria.
  • the obtained product has a molecular weight of 10 6 to 10 8 g/mol and a dispersed molecular density of 1000 to 2000 g/(mol ⁇ nm 3 ).
  • the mass concentration of the natural glucosyl nanoparticles in step (1) in water is 10-40%.
  • the reaction in step (1) is catalyzed at a constant temperature at a temperature of 30 to 70° C. and a pH value of 3.5 to 7.0 for 0.5 to 12 hours.
  • the microbial GH13 family glycoside hydrolase includes one or more of maltosidase, amyloglucosidase, starch hydrolase and the like.
  • the organic acid anhydride esterification agent includes one or more of succinic anhydride, maleic anhydride, acetic anhydride, stearic acid anhydride, citric acid anhydride, etc.
  • the etherification agent includes epichlorohydrin, epoxy One or more of ethylene, methyl chloride, ethyl chloride, dimethyl sulfuric acid, etc.
  • the addition amount of the organic acid anhydride esterification agent in step (2) is 0.5% to 3% relative to the mass of the natural glucosyl nanoparticles.
  • the addition amount of the etherification reagent in step (2) is 1%-10% relative to the mass of the natural glucosyl nanoparticles.
  • the power of the microwave in the step (2) is 400-1000W.
  • the reaction in the step (2) is a reaction at 30-50°C for 1-10h.
  • the preservative includes one or more of nisin, lysozyme, chitin, ⁇ -polylysine, natamycin, thymol, eugenol, Gemini quaternary ammonium salt, etc. .
  • the frequency of ultrasound in step (3) is 20-100 kHz.
  • the reaction in step (3) is to react at 20-50°C for 0.1-5h to realize charge transfer.
  • the second object of the present invention is to prepare a nano antibacterial glucosyl composite particle by using the above method.
  • the third objective of the present invention is to apply the above-mentioned nano antibacterial glucose-based composite particles to food active packaging, cosmetics, textiles, hydrogels, adhesives and the like.
  • the raw materials of the present invention have a wide range of sources, including grains, algae, animals or microorganisms, and are not restricted by the place of production and the season.
  • the nano-antibacterial glucose-based composite particles have a particle size of 50-1000nm, a surface zeta potential of 0-10mV, and a broad-spectrum antibacterial rate >98%; they can be used in many fields such as food, textiles, daily chemicals, medicine, etc. Such as food active packaging, cosmetics, textiles, hydrogels, adhesives, etc. have application prospects.
  • Figure 1 is an electron micrograph (bar 100nm) of the nano antibacterial glucosyl composite particles obtained in Example 1.
  • E.coli, Staphylococcus aureus (S.aureus), Salmonella typhimurium (S.typhimurium), Listeria monocytogenes (L.monocytogenes) and other food-borne spoilage bacteria are cultivated on nutrient agar After streaking on the base and culturing at 37°C for 12h, pick a single colony, and then incubate it in a nutrient broth medium at 37°C for 12h, count the plates, and draw a certain amount of bacteria in 100mL nutrient broth medium (the final is 107CFU/mL), then put an appropriate amount of nano antibacterial glucosyl composite particles, incubate in a constant temperature incubator at 37°C, and measure the OD600 value of the sample at 0h, 4h, 6h, 8h, 10h, 12h and 24h, respectively. The samples cultured for 12 hours are counted on the plate to determine the antibacterial rate. Each group of samples is paralleled three times, and the calculation formula
  • nano-antibacterial glucosyl composite particles to be tested were formulated into a 0.1% (w/v) solution, and the surface zeta potential was measured with a Malvern Nano ZS meter at 25°C.
  • the source of natural glucosyl nanoparticles can be obtained by extracting from growing grain grains, algae and certain animal tissues by using existing technical means, or by extracting bacteria from microorganisms through activation culture and fermentation. Specific reference can be made to the literature: Structure and digestibility of endosperm water-soluble a-glucans from different sugar maize mutants, Food Chemistry 143 (2014) 156-162.
  • the obtained target product has an average particle size of 110 nm, a surface zeta potential of -5.2 mV, and a broad-spectrum antibacterial rate of 98.7%.
  • the obtained target product has an average particle size of 170nm, a surface zeta potential of -7.5mV, and a broad-spectrum bacteriostatic rate of 99.4%.
  • the obtained target product has an average particle size of 290 nm, a surface zeta potential of -1.2 mV, and a broad-spectrum antibacterial rate of 99.3%.
  • Example 1 With reference to Example 1, the dosages of the microbial GH13 family glycoside hydrolase were replaced with 30 U/g and 300 U/g, and other conditions were unchanged, respectively, and corresponding composite particles were prepared. The properties of composite particles were measured, and the structure is shown in Table 1.
  • Enzyme dosage (U/g) Surface zeta potential (mV) Antibacterial rate (%) 30 -11.2 75.2
  • the dosage of enzyme is too low or the dosage of enzyme is too high, the surface charge of the obtained composite particles is less than -10mV, and the antibacterial rate is also less than 90%.
  • glucosyl nanoparticles [2.3 ⁇ 10 7 g/mol, dispersed molecular density 1230g/(mol ⁇ nm 3 )] derived from oysters to form a uniform aqueous solution with a mass percentage concentration of 40%, and add 200 U/g substrate Microbial GH13 family amyloglucosidase, adjust the parameters of the reaction system: temperature 50°C, pH value 7.0, constant temperature catalysis for 0.5h; add 0.5% succinic anhydride and 3% ethylene oxide, and adjust the pH of the reaction system to 12.
  • the microwave power is adjusted to 800W, and the reaction is carried out at 50°C for 6 hours; then the target product is obtained by precipitation and drying treatment.
  • the surface zeta potential of the obtained target product is -32.5mV, and the broad-spectrum bacteriostatic rate is 0%. It can be seen that the antibacterial activity of simple nano-glucose-based particles is zero. In addition, using the same amount of chitin for antibacterial experiments, it was found that the broad-spectrum antibacterial rate was 89.4%.
  • the obtained target product has an average particle size of 625 nm, a surface zeta potential of -9.2 mV, and a broad-spectrum antibacterial rate of 91.7%.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Nanotechnology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dentistry (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Composite Materials (AREA)
  • Pest Control & Pesticides (AREA)
  • General Physics & Mathematics (AREA)
  • Materials Engineering (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Cosmetics (AREA)
  • Microbiology (AREA)

Abstract

公开了一种纳米抗菌葡糖基复合粒子及其加工方法与应用，属于现代食品加工技术领域。以天然葡糖基纳米颗粒为原料，利用颗粒表面定位改性与物理场电荷转移技术来制备纳米抗菌复合粒子。所得纳米抗菌葡糖基复合粒子的粒径50～1000nm，表面zeta电位0～-10mV，广谱抑菌率>98％；能够有效延长食品的货架期，防止产品腐败变质；可用于食品、纺织、日化、医药等诸多领域等领域，应用前景广阔。

Description

一种纳米抗菌葡糖基复合粒子及其加工方法与应用 技术领域
本发明涉及一种纳米抗菌葡糖基复合粒子及其加工方法与应用，属于现代食品加工技术领域。
背景技术
纳米技术是上世纪80年代末期崛起并正在迅猛发展的新型前沿高技术，涉及现代物理学、化学、生物学、医学、材料科学、信息科学、能源科学和先进制造科学，是一门高度交叉学科。纳米技术是研究在纳米尺度(通常指1～100nm)下材料的性质和应用。利用纳米技术可以使人类认识与改造物质世界的手段和能力延伸到原子和分子。在纳米尺度下，物质具有量子尺寸效应、表面效应和宏观量子隧道效应等特点，展现出与宏观尺度下物质的物理、化学、光学、力学、生物学等不同或宏观不具备的特性。目前，纳米科技已经对世界产生了深远影响，其应用领域已慢慢渗入到食品、农业、医药等传统产业中，欧美发达国家已投入大量的人力物力进行纳米尺度系列产品的研究与开发，如活性因子纳米载体、食品抗菌包装、纳米封装化学投入品、纳米乳液、纳米传感器等。
近年来，由于抗生素的滥用导致了全球范围内不断的出现多药耐药菌株，新型高效抗菌剂的研究越来越受到重视，其中金属及金属氧化物的纳米粒子具备高效抗菌活性，如Ag、TiO 2、ZnO、Fe 3O 4等，他们破坏细菌细胞壁或细胞膜、阻断跨膜的电子转移、抑制酶活性和DNA合成等。但是，这些纳米抗菌粒子存在安全性、成本高、药效不佳等问题，如纳米Ag和纳米TiO 2都具有一定程度的毒性，可能会对人体健康和环境产生负面影响，而对天然可降解生物大分子物质制备抗菌纳米粒子的研究报道较少，至今未见纳米抗菌葡糖基复合粒子相关报道。基于上述原因，为了拓宽天然纳米材料的应用领域并提升附加值，开发一种纳米抗菌葡糖基复合粒子加工方法与应用是有迫切需求的。
发明内容
为了解决上述问题，本发明提供了一种纳米抗菌葡糖基复合粒子，本发明纳米抗菌葡糖基复合粒子具有优异的抗菌性能，可以作为基体材料用于食品、纺织、日化、医药等领域。该方法具有工艺简单、过程可控、绿色环保等特点。
本发明的第一个目的是提供一种纳米抗菌葡糖基复合粒子的加工方法，所述方法包括如 下步骤：
(1)将天然葡糖基纳米颗粒分散在水中，添加50～200U/g天然葡糖基纳米颗粒的微生物GH13家族糖苷水解酶进行催化反应；
(2)反应完全后，加入有机酸酐酯化剂、醚化试剂，调节pH至7～13，微波环境下进行反应；
(3)反应完全后，加入相对天然葡糖基纳米颗粒0.01-1％质量百分比的防腐剂，超声环境下进行反应，然后取沉淀、干燥。
在本发明实施方式中，天然葡糖基纳米颗粒来源于植物、动物或微生物，其中植物和动物源采用生长期谷物籽粒、藻类和动物某些组织提取获得，微生生物源经过活化培养、发酵获得菌体提取获得。所得产物分子量10 6～10 8g/mol，分散分子密度1000～2000g/(mol·nm 3)。
在本发明实施方式中，步骤(1)中的天然葡糖基纳米颗粒在水中的质量浓度为10～40％。
在本发明实施方式中，步骤(1)中的反应是在温度30～70℃、pH值3.5～7.0下恒温催化0.5～12h。
在本发明实施方式中，微生物GH13家族糖苷水解酶包括麦芽糖苷酶、淀粉葡糖苷酶、淀粉水解酶等一种或多种。
在本发明实施方式中，有机酸酐酯化剂包括丁二酸酐、顺丁烯二酸酐、乙酸酐、硬脂酸酐、柠檬酸酐等一种或多种，醚化试剂包括环氧氯丙烷、环氧乙烯、甲基氯、乙基氯、二甲基硫酸等一种或多种。
在本发明实施方式中，步骤(2)中的有机酸酐酯化剂的添加量为相对天然葡糖基纳米颗粒质量的0.5％～3％。
在本发明实施方式中，步骤(2)中的醚化试剂的添加量为相对天然葡糖基纳米颗粒质量的1％～10％。
在本发明实施方式中，所述步骤(2)中微波的功率为400～1000W。所述步骤(2)中的反应是在30～50℃条件下反应1～10h。
在本发明实施方式中，防腐剂包括乳酸链球菌素、溶菌酶、甲壳素、ε-聚赖氨酸、纳他霉素、百里酚、丁香酚、Gemini季铵盐等一种或多种。
在本发明实施方式中，步骤(3)中超声的频率20～100kHz。步骤(3)中的反应是在20～50℃条件下反应0.1～5h，实现电荷转移。
本发明的第二个目的是利用上述方法制备得到一种纳米抗菌葡糖基复合粒子。
本发明的第三个目的是将上述的纳米抗菌葡糖基复合粒子应用于食品活性包装、化妆品、 纺织品、水凝胶、胶黏剂等方面。
本发明具有以下优点：
1.本发明原料来源广，包括谷物、藻类、动物或微生物，不受产地和季节的限制。
2.以天然葡糖基纳米粒子为原料，利用颗粒表面定位改性与物理场电荷转移技术来制备纳米抗菌复合粒子，应用于抗菌膜及其他表面接触类包装能够有效延长食品的货架期，防止产品腐败变质；
3.该纳米抗菌葡糖基复合粒子的粒径50～1000nm，表面zeta电位0～-10mV，广谱抑菌率>98％；可用于食品、纺织、日化、医药等诸多领域等领域，如食品活性包装、化妆品、纺织品、水凝胶、胶黏剂等方面具有应用前景。
附图说明
图1为实施例1所得纳米抗菌葡糖基复合粒子的电镜照片(bar 100nm)。
具体实施方式
广谱抑菌率测定方法：
大肠杆菌(E.coli)、金黄色葡萄球菌(S.aureus)、鼠伤寒沙门氏菌(S.typhimurium)、单核细胞增生李斯特菌(L.monocytogenes)等食源性腐败菌种于营养琼脂培养基上划线，37℃培养12h后，挑取单菌落，再于营养肉汤培养基中37℃培养12h，平板计数，并吸取一定量的菌液于100mL营养肉汤培养基中(最终为107CFU/mL)，再适量放入纳米抗菌葡糖基复合粒子，于恒温培养箱中37℃培养，分别在0h、4h、6h、8h、10h、12h和24h测定试样的OD600值，并对培养12h的样品进行平板计数，以测定其抑菌率大小，每组样品三次平行，计算公式如下：
Figure PCTCN2020129605-appb-000001
表面zeta电位测定方法：
将待测纳米抗菌葡糖基复合粒子配制成0.1％(w/v)的溶液，25℃下用马尔文Nano ZS测定仪进行表面zeta电位测定。
天然葡糖基纳米颗粒来源：可利用现有技术手段从生长期谷物籽粒、藻类和动物某些组织提取获得，或者微生物经过活化培养、发酵获得菌体提取获得。具体可参考文献制得：Structure and digestibility of endosperm water-soluble a-glucans from different sugary maize mutants，Food Chemistry 143(2014)156–162。
实施例1
称取来源于牡蛎的葡糖基纳米颗粒【2.3×10 7g/mol，分散分子密度1230g/(mol·nm 3】配成质量百分比浓度40％的均一水溶液，添加200U/g底物的微生物GH13家族淀粉葡糖苷酶，调节反应体系参数：温度50℃、pH值7.0，恒温催化0.5h；加入底物质量百分比0.5％丁二酸酐、3％环氧乙烯，调节反应体系pH 12，同时结合微波辅助加工技术，调节微波功率800W，50℃条件下反应6h；加入底物质量百分比0.01％甲壳素，利用物理场电荷转移技术，控制超声频率100kHz，20℃条件下反应0.5h，然后沉淀、干燥处理即得到目标产物。
所得目标产物的平均粒径110nm，表面zeta电位-5.2mV，广谱抑菌率98.7％。
实施例2
称取来源于稻米的葡糖基纳米颗粒【7.3×10 6g/mol，分散分子密度1510(mol·nm 3)】配成质量百分比浓度10％的均一水溶液，添加50U/g底物的微生物GH13家族麦芽糖苷酶，调节反应体系参数：温度30℃、pH值6.0，恒温催化8h；加入底物质量百分比3％乙酸酐、1％环氧乙烯，调节反应体系pH 10，同时结合微波辅助加工技术，调节微波功率400W，30℃条件下反应10h；加入底物质量百分比0.5％乳酸链球菌素，利用物理场电荷转移技术，控制超声频率50kHz，50℃条件下反应2h，然后沉淀、干燥处理即得到目标产物。
所得目标产物的平均粒径170nm，表面zeta电位-7.5mV，广谱抑菌率99.4％。
实施例3
称取来源于马克斯克鲁维酵母的葡糖基纳米颗粒【1.8×10 6g/mol，分散分子密度1080g/(mol·nm 3)】配成质量百分比浓度20％的均一水溶液，添加100U/g底物的微生物GH13家族麦芽糖苷酶，调节反应体系参数：温度60℃、pH值5.0，恒温催化2h；加入底物质量百分比1％顺丁烯二酸酐、5％乙基氯，调节反应体系pH 8，同时结合微波辅助加工技术，调节微波功率500W，35℃条件下反应3h；加入底物质量百分比1％溶菌酶，利用物理场电荷转移技术，控制超声频率80kHz，30℃条件下反应1h，然后沉淀、干燥处理即得到目标产物。
所得目标产物的平均粒径290nm，表面zeta电位-1.2mV，广谱抑菌率99.3％。
实施例4优化酶的用量
参考实施例1，将微生物GH13家族糖苷水解酶的用量分别替换为30U/g、300U/g，其他条件不变，分别制得相应的复合粒子。测定复合粒子的性能，结构见表1。
表1不同酶用量制得的复合粒子的性能结果
酶用量(U/g) 表面zeta电位(mV) 抑菌率(％)
30 -11.2 75.2
300 -10.5 80.2
结果发现，酶用量过低或酶用量过高，得到复合粒子的表面电荷均小于-10mV，抑菌率也均低于90％。
对比例1
称取来源于牡蛎的葡糖基纳米颗粒【2.3×10 7g/mol，分散分子密度1230g/(mol·nm 3)】配成质量百分比浓度40％的均一水溶液，添加200U/g底物的微生物GH13家族淀粉葡糖苷酶，调节反应体系参数：温度50℃、pH值7.0，恒温催化0.5h；加入底物质量百分比0.5％丁二酸酐、3％环氧乙烯，调节反应体系pH 12，同时结合微波辅助加工技术，调节微波功率800W，50℃条件下反应6h；然后沉淀、干燥处理即得到目标产物。
所得目标产物的表面zeta电位-32.5mV，广谱抑菌率0％。可见，单纯的纳米葡糖基粒子的抗菌活性为0。此外，单纯利用等量的甲壳素进行抗菌实验，发现广谱抑菌率为89.4％。
对比例2
称取来源于牡蛎的葡糖基纳米颗粒【2.3×10 7g/mol，分散分子密度1230g/(mol·nm 3】配成质量百分比浓度40％的均一水溶液，添加200U/g底物的微生物GH13家族淀粉葡糖苷酶，调节反应体系参数：温度50℃、pH值7.0，恒温催化0.5h；加入底物质量百分比0.5％丁二酸酐、3％环氧乙烯，调节反应体系pH 12，同时结合微波辅助加工技术，调节微波功率800W，50℃条件下反应6h；加入底物质量百分比0.01％甲壳素，省略超声电荷转移过程，在20℃条件下直接搅拌反应0.5h，然后沉淀、干燥处理即得到目标产物。
所得目标产物的平均粒径625nm，表面zeta电位-9.2mV，广谱抑菌率91.7％。

Claims (10)

  1. 一种纳米抗菌葡糖基复合粒子的加工方法，其特征在于，所述方法包括如下步骤：
    (1)将天然葡糖基纳米颗粒分散在水中，添加50～200U/g天然葡糖基纳米颗粒的微生物GH13家族糖苷水解酶进行催化反应；
    (2)反应完全后，加入有机酸酐酯化剂、醚化试剂，调节pH至7～13，微波环境下进行反应；
    (3)反应完全后，加入相对天然葡糖基纳米颗粒0.01-1％质量百分比的防腐剂，超声环境下进行反应，然后沉淀、干燥。
  2. 根据权利要求1所述的方法，其特征在于，所述天然葡糖基纳米颗粒的分子量为10 6g/mol～10 8g/mol，分散分子密度(1000～2000)g·mol -1·nm -3。
  3. 根据权利要求1所述的方法，其特征在于，步骤(1)中的天然葡糖基纳米颗粒在水中的质量浓度为10～40％。
  4. 根据权利要求1所述的方法，其特征在于，步骤(1)中的反应是在温度30～70℃、pH值3.5～7.0下恒温催化0.5～12h。
  5. 根据权利要求1所述的方法，其特征在于，步骤(2)中的有机酸酐酯化剂的添加量为相对天然葡糖基纳米颗粒质量的0.5％～3％。
  6. 根据权利要求1所述的方法，其特征在于，步骤(2)中的醚化试剂的添加量为相对天然葡糖基纳米颗粒质量的1％～10％。
  7. 根据权利要求1所述的方法，其特征在于，步骤(3)中超声的频率20～100kHz。步骤(3)中的反应是在20～50℃条件下反应0.1～5h，实现电荷转移。
  8. 根据权利要求1所述的方法，其特征在于，防腐剂包括乳酸链球菌素、溶菌酶、甲壳素、ε-聚赖氨酸、纳他霉素、百里酚、丁香酚、Gemini季铵盐中的一种或多种。
  9. 权利要求1-8任一所述的方法制得的纳米抗菌葡糖基复合粒子。
  10. 权利要求9所述的纳米抗菌葡糖基复合粒子在食品活性包装、化妆品、纺织品、水凝胶、胶黏剂方面的应用。
PCT/CN2020/129605 2019-11-19 2020-11-18 一种纳米抗菌葡糖基复合粒子及其加工方法与应用 Ceased WO2021098693A1 (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17/744,811 US12336546B2 (en) 2019-11-19 2022-05-16 Antibacterial glucose-based composite nanoparticle and processing method and use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201911134115.9A CN110859184B (zh) 2019-11-19 2019-11-19 一种纳米抗菌葡糖基复合粒子及其加工方法与应用
CN201911134115.9 2019-11-19

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US17/744,811 Continuation US12336546B2 (en) 2019-11-19 2022-05-16 Antibacterial glucose-based composite nanoparticle and processing method and use thereof

Publications (1)

Publication Number Publication Date
WO2021098693A1 true WO2021098693A1 (zh) 2021-05-27

Family

ID=69655577

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/129605 Ceased WO2021098693A1 (zh) 2019-11-19 2020-11-18 一种纳米抗菌葡糖基复合粒子及其加工方法与应用

Country Status (3)

Country Link
US (1) US12336546B2 (zh)
CN (1) CN110859184B (zh)
WO (1) WO2021098693A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110859184B (zh) 2019-11-19 2021-07-27 江南大学 一种纳米抗菌葡糖基复合粒子及其加工方法与应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102726729A (zh) * 2012-07-16 2012-10-17 江南大学 一种适用于液态功能食品体系的葡聚糖基载体材料的加工方法
CN102924623A (zh) * 2012-11-22 2013-02-13 江南大学 一种改善交替糖物性的加工方法
CN108424942A (zh) * 2018-02-08 2018-08-21 江南大学 一种葡糖基壳核结构的载体材料及其制备与应用
CN110859184A (zh) * 2019-11-19 2020-03-06 江南大学 一种纳米抗菌葡糖基复合粒子及其加工方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102016010730A2 (pt) * 2016-05-12 2017-11-28 Universidade Estadual De Feira De Santana Production and application of microparticles generated from aquarium starch

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102726729A (zh) * 2012-07-16 2012-10-17 江南大学 一种适用于液态功能食品体系的葡聚糖基载体材料的加工方法
CN102924623A (zh) * 2012-11-22 2013-02-13 江南大学 一种改善交替糖物性的加工方法
CN108424942A (zh) * 2018-02-08 2018-08-21 江南大学 一种葡糖基壳核结构的载体材料及其制备与应用
CN110859184A (zh) * 2019-11-19 2020-03-06 江南大学 一种纳米抗菌葡糖基复合粒子及其加工方法与应用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BI, LIN ET AL.: "Designing carbohydrate nanoparticles for prolonged efficacy of antimicrobial peptide", JOURNAL OF CONTROLLED RELEASE, vol. 150, no. 2, 27 November 2010 (2010-11-27), XP028155807, DOI: 10.1016/j.jconrel.2010.11.024 *

Also Published As

Publication number Publication date
CN110859184B (zh) 2021-07-27
US20220273004A1 (en) 2022-09-01
US12336546B2 (en) 2025-06-24
CN110859184A (zh) 2020-03-06

Similar Documents

Publication Publication Date Title
CN101781374B (zh) 壳聚糖和/或其衍生物铜复合物的制备方法及应用
Rajeshkumar et al. Antimicrobial activity of probiotic bacteria-mediated cadmium oxide nanoparticles against fish pathogens
CN102816349A (zh) 一种壳聚糖/纳米TiO2复合材料及其制备方法和应用
CN111847525B (zh) 一种水葫芦绿色合成磁性纳米Fe3O4颗粒的方法及应用
Oudhia et al. Green synthesis of ZnO nanotubes for bioapplications
CN115646486A (zh) 一种石墨烯负载钯纳米酶及其制备方法和应用
CN103642844A (zh) 一种利用芽孢杆菌体内还原制备纳米银颗粒的方法
US12336546B2 (en) Antibacterial glucose-based composite nanoparticle and processing method and use thereof
CN103054129A (zh) 纳米氧化锌作为抗菌剂的应用
CN109964957A (zh) 一种Cu2O/Ag纳米抗菌材料的绿色制备方法
Rybalchenko et al. Antimicrobial effect of biopolymer packaging materials with silver nanoparticles for food storage
CN113957099A (zh) 一种基于苏云金芽孢杆菌的纳米氧化锌复合材料及其制备方法与应用
Yang et al. Facile one-precursor and one-pot synthesis of Girard’s reagent T-based carbon dots for bacteria-resistant and anti-biofilm applications
CN110078101B (zh) 一种抗茶叶真菌病害纳米氢氧化镁的制备与应用
CN109735576B (zh) 一种利用细菌上清制备纳米金属氧化物的方法及其产品和应用
CN116060042B (zh) 一种PDA/BiOCl光催化材料、制备方法与应用
CN104480025B (zh) 一种链格孢菌y1309‑1及其应用
CN103406548B (zh) 银纳米粒子及其制备方法与应用
Joshi et al. Synergistic effect of copper, silver nanoparticles and hydrogen peroxide on Xanthomonas axonopodis pv. punicae
CN114129727B (zh) 一种硼纳米片复合材料及其制备方法
CN116135309B (zh) 一种高效杀灭产毒黄曲霉菌的绿色方法
CN109526981A (zh) 一种纳米复合材料g-C3N4/Ni及其制备方法与应用
CN111039270B (zh) 一种花状磷酸锌纳米颗粒抑菌材料及其制备方法与用途
CN116004435A (zh) 一种巨大芽孢杆菌及其应用
CN118419965B (zh) 一种氧化锌纳米花及其制备方法和应用

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20889838

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20889838

Country of ref document: EP

Kind code of ref document: A1